G. Hofmockel

776 total citations
44 papers, 552 citations indexed

About

G. Hofmockel is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Oncology. According to data from OpenAlex, G. Hofmockel has authored 44 papers receiving a total of 552 indexed citations (citations by other indexed papers that have themselves been cited), including 20 papers in Pulmonary and Respiratory Medicine, 16 papers in Surgery and 12 papers in Oncology. Recurrent topics in G. Hofmockel's work include Renal cell carcinoma treatment (8 papers), Cancer Research and Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). G. Hofmockel is often cited by papers focused on Renal cell carcinoma treatment (8 papers), Cancer Research and Treatments (6 papers) and Cancer Immunotherapy and Biomarkers (6 papers). G. Hofmockel collaborates with scholars based in Germany. G. Hofmockel's co-authors include H. Frohmüller, J Dämmrich, Ioannis D. Bassukas, M. Theiß, Wolfgang Langer, B. Maurer‐Schultze, Michael C. Truß, Michael Probst, Serdar Değer and Heiko Müller and has published in prestigious journals such as Cancer, The Journal of Urology and European Urology.

In The Last Decade

G. Hofmockel

41 papers receiving 517 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
G. Hofmockel Germany 11 331 198 167 162 114 44 552
Özden Tulunay Türkiye 15 243 0.7× 185 0.9× 100 0.6× 185 1.1× 63 0.6× 50 635
Walter Henriques da Costa Brazil 15 216 0.7× 220 1.1× 108 0.6× 199 1.2× 90 0.8× 44 489
L Boccon-Gibod France 9 422 1.3× 156 0.8× 76 0.5× 269 1.7× 115 1.0× 40 585
R E Scully United States 13 162 0.5× 251 1.3× 142 0.9× 79 0.5× 53 0.5× 13 916
C Billerey France 12 124 0.4× 526 2.7× 108 0.6× 365 2.3× 63 0.6× 42 854
Pacita Keh United States 16 107 0.3× 236 1.2× 118 0.7× 83 0.5× 55 0.5× 24 585
L Boccon-Gibod France 12 407 1.2× 146 0.7× 51 0.3× 167 1.0× 96 0.8× 49 565
Sebastian Frees Germany 13 212 0.6× 146 0.7× 93 0.6× 126 0.8× 55 0.5× 37 445
Anne-Birgitte Jacobsen Norway 13 141 0.4× 196 1.0× 184 1.1× 45 0.3× 84 0.7× 30 452
Pridvi Kandagatla United States 9 105 0.3× 87 0.4× 178 1.1× 109 0.7× 50 0.4× 29 423

Countries citing papers authored by G. Hofmockel

Since Specialization
Citations

This map shows the geographic impact of G. Hofmockel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by G. Hofmockel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites G. Hofmockel more than expected).

Fields of papers citing papers by G. Hofmockel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by G. Hofmockel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by G. Hofmockel. The network helps show where G. Hofmockel may publish in the future.

Co-authorship network of co-authors of G. Hofmockel

This figure shows the co-authorship network connecting the top 25 collaborators of G. Hofmockel. A scholar is included among the top collaborators of G. Hofmockel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with G. Hofmockel. G. Hofmockel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Theiß, M., et al.. (2008). Laparoskopie in der Urologie: Bestandsaufnahme und Perspektiven. DMW - Deutsche Medizinische Wochenschrift. 118(37). 1331–1335.
2.
Rassweiler, Jens, Jens Uwe Stolzenburg, Tullio Sulser, et al.. (2005). Laparoscopic Radical Prostatectomy - the Experience of the German Laparoscopic Working Group. European Urology. 49(1). 113–119. 100 indexed citations
4.
Hofmockel, G., et al.. (2000). Molekulargenetische und zellbiologische Grundlagen der Entstehung von malignen Tumoren. Der Urologe. 39(3). 214–221. 1 indexed citations
5.
Hofmockel, G., et al.. (1998). Lipoma of the adrenal gland. Case report and review of the literature. Der Urologe. 37(5). 526–529. 3 indexed citations
6.
Hofmockel, G., et al.. (1997). Epidermal Growth Factor Family and Renal Cell Carcinoma: Expression and Prognostic Impact. European Urology. 31(4). 478–484. 42 indexed citations
7.
Hofmockel, G., et al.. (1997). Is the expression of multidrug resistance gene product a prognostic indicator for the clinical outcome of patients with renal cancer?. British Journal of Urology. 80(1). 11–17. 14 indexed citations
8.
Hofmockel, G., et al.. (1997). Cyclic Interf eron Alpha Treatment in Metastatic Renal Cell Carcinoma: Results of a Phase II Study and Review of the Literature. Urologia Internationalis. 58(1). 8–12. 5 indexed citations
9.
Theiß, M., Wolfgang Langer, G. Hofmockel, & H. Frohmüller. (1997). Radical prostatectomy as primary monotherapy in capsular-penetrating prostate cancer. Results over 15 years. Der Urologe. 36(4). 343–347. 2 indexed citations
10.
Hofmockel, G., et al.. (1997). Immunchemotherapie des metastasierten Nierenzell- karzinoms mit Interleukin-2, Interferon-? und 5-Fluorouracil. Der Urologe. 36(1). 45–49. 3 indexed citations
11.
Langer, Wolfgang, G. Hofmockel, M. Theiß, & H. Frohmüller. (1997). Surgical treatment of metastases in patients with renal cell carcinoma. Der Urologe. 36(6). 548–551. 2 indexed citations
12.
Hofmockel, G., et al.. (1996). Immunochemotherapy for metastatic renal cell carcinoma using a regimen of interleukin-2, interferon-alpha and 5-fluorouracil.. PubMed. 156(1). 18–21. 65 indexed citations
13.
Hofmockel, G., et al.. (1996). Chemotherapy in Advanced Seminoma and the Role of Postcytostatic Retroperitoneal Lymph Node Dissection. Urologia Internationalis. 57(1). 38–42. 10 indexed citations
14.
Bassukas, Ioannis D., et al.. (1996). Prognostic relevance of the intrinsic growth deceleration of the first passage xenografts of human renal cell carcinomas. Cancer. 78(10). 2170–2172. 5 indexed citations
15.
Theiß, M., G. Hofmockel, P. Eckert, & H. Frohmüller. (1996). [Cosmetic and functional long-term outcome after operation of Fournier gangrene].. PubMed. 35(4). 338–41. 8 indexed citations
16.
Hofmockel, G., Heiko Müller, J Dämmrich, et al.. (1995). Significance of conventional and new prognostic factors for locally confined renal cell carcinoma. Cancer. 76(2). 296–306. 58 indexed citations
17.
Maurer‐Schultze, B., et al.. (1995). Effect of biological response modifiers on growth and cell proliferation of human tumor xenografts in nude mice.. PubMed. 41(1). 65–78. 5 indexed citations
18.
Hofmockel, G., et al.. (1995). Fournier's gangrene in a patient with erectile dysfunction following use of a mechanical erection aid device.. PubMed. 153(6). 1921–2. 23 indexed citations
19.
Hofmockel, G., et al.. (1995). Primary Non-Hodgkin’s Lymphoma of the Male Urethra. Urologia Internationalis. 55(3). 177–180. 8 indexed citations
20.
Bassukas, Ioannis D., G. Hofmockel, & B. Maurer‐Schultze. (1994). Treatment with tumor necrosis factor alpha and interferon alpha of a human kidney cancer xenograft in nude mice: evidence for an anticachectic effect of interferon alpha.. PubMed. 14(1A). 237–45. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026